➤ Subscribe for Complete Access

Flexible subscription options to meet your unique needs…

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Colorcon
Johnson and Johnson
Harvard Business School
Merck

Last Updated: November 27, 2021

DrugPatentWatch Database Preview

Patent: 6,955,717

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 6,955,717
Title: Crystals and structure of Synagis Fab
Abstract:The present invention provides machine readable media embedded with the three-dimensional atomic structure coordinates of Synagis Fab, and subsets thereof, and methods of using them.
Inventor(s): Johnson; Leslie S. (Darnestown, MD), Braden; Bradford (Baltimore, MD)
Assignee: Medimmune Inc. (Gaithersburg, MD) Bowie State University (Bowie, MD)
Application Number:10/135,636
Patent Claims:see list of patent claims

Details for Patent 6,955,717

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Swedish Orphan Biovitrum Ab (publ) SYNAGIS palivizumab For Injection 103770 1998-06-19 ⤷  Try it Free 2021-05-01
Swedish Orphan Biovitrum Ab (publ) SYNAGIS palivizumab Injection 103770 2004-07-23 ⤷  Try it Free 2021-05-01
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Baxter
Johnson and Johnson
Boehringer Ingelheim
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.